Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Pérez, Cecilia V ^a   Gómez, Leticia G ^a   Gualdoni, Gisela S ^a   Lustig, Livia ^a   Rabinovich, Gabriel A ^a,b   Guazzone, Vanesa A ^a  

^a Instituto de Investigaciones Biomédicas ^*  (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1;

ANIMAL; APOPTOSIS; AUTOIMMUNE DISEASE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; MOUSE; ORCHITIS; PATHOLOGY; SEMINIFEROUS TUBULE; SPERMATOCYTE;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; GALECTIN 1; MALE; MICE; MICE, KNOCKOUT; ORCHITIS; SEMINIFEROUS TUBULES; SPERMATOCYTES;

EID: 84938369571     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12259     Document Type: Article

References (49)

1. Yang, R. Y., Rabinovich, G. A. & Liu, F. T. Galectins: structure, function and therapeutic potential. Expert. Rev. Mol. Med. 10, e17 (2008).
2. Rabinovich, G. A. & Ilarregui, J. M. Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol. Rev. 230, 144-159 (2009).
3. Rabinovich, G. A. & Croci, D. O. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 36, 322-335 (2012).
4. Croci, D. O. et al. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. J. Exp. Med. 209, 1985-2000 (2012).
5. Thijssen, V. L., Rabinovich, G. A. & Griffioen, A. W. Vascular galectins: regulators of tumor progression and targets for cancer therapy. Cytokine Growth Factor Rev. 24, 547-558 (2013).
6. Croci, D. O. et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156, 744-758 (2014).
7. Freitag, N. et al. Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia. Proc. Natl. Ac. Sci. USA. 110, 11451-11456 (2013).
8. Bastón, J. I. et al. Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis. J. Pathol. 234, 329-337 (2014).
9. Dettin, L., Rubinstein, N., Aoki, A., Rabinovich, G. A. & Maldonado, C. A. Regulated expression and ultrastructural localization of galectin-1, a proapoptotic beta-galactoside-binding lectin, during spermatogenesis in rat testis. Biol. Reprod. 68, 51-59 (2003).
10. Wollina, U. et al. Sertoli cell expression of galectin-1 and-3 and accessible binding sites in normal human testis and Sertoli cell only-syndrome. Histol. Histopatho. 14, 779-784 (1999).
11. Chui, K. et al. Characterization and functionality of proliferative human Sertoli cells. Cell Transplant. 20, 619-635 (2011).
12. Munn, D. H. & Mellor, A. L. The tumor-draining lymph node as an immune-privileged site. Immunol. Rev. 213, 146-158 (2006).
13. Jacobo, P., Guazzone, V. A., Theas, M. S. & Lustig, L. Testicular autoimmunity. Autoimmun. Rev. 10, 201-204 (2011).
14. Chemes, H. The phagocytic function of Sertoli cells: a morphological, biochemical, and endocrinological study of lysosomes and acid phosphatase localization in the rat testis. Endocrinology 119, 1673-1681 (1986).
15. Pineau, C., Le Magueresse, B., Courtens, J. L. & Jégou, B. Study in vitro of the phagocytic function of Sertoli cells in the rat. Cell Tissue Res. 264, 589-598 (1991).
16. Miething, A. Germ-cell death during prespermatogenesis in the testis of the golden hamster. Cell Tissue Res. 267, 583-590 (1992).
17. Head, J. R., Neaves, W. B. & Billingham, R. E. Immune privilege in the testis. I. Basic parameters of allograft survival. Transplantation 36, 423-431 (1983).
18. Kuopio, T., Savouras, P. O., Pelliniemi, L. J. & Huhtaniemi, I. T. Transplantation of newborn rat testis under the kidney capsule of adult host as a model to study the structure and function of Leydig cells. J. Androl. 10, 335-345 (1989).
19. Ma, P. et al. Spermatogenesis following syngeneic testicular transplantation in Balb/c mice. Reproduction 128, 163-170 (2004).
20. Selawry, H. P. & Cameron, D. F. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. 2, 123-129 (1993).
21. Mital, P., Kaur, G. & Dufour, J. M. Immunoprotective Sertoli cells: making allogeneic and xenogeneic transplantation feasible. Reproduction 139, 495-504 (2010).
22. Dal Secco, V., Riccioli, A., Padula, F., Ziparo, E. & Filippini, A. Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma. Biol. Reprod. 78, 234-242 (2008).
23. Pérez, C. V. et al. Dual role of immune cells in the testis. Protective or pathogenic for germ cells? Spermatogenesis 3, 1-12 (2013).
24. Tung, K. S., Yule, T. D., Mahi-Brown, C. A. & Listrom, M. B. Distribution of histopathology and Ia positive cells in actively induced and passively transferred experimental autoimmune orchitis. J. Immunol. 138, 752-759 (1987).
25. Guazzone, V. A., Jacobo, P., Theas, M. S. & Lustig, L. Cytokines and chemokines in testicular inflammation: A brief review. Microsc. Res. Tech. 72, 620-628 (2009).
26. Lustig, L., Rival, C. & Tung, K. S. K. Autoimmune orchitis and autoimmune oophoritis. In The Autoimmune Diseases, (5th edn), [N. Rose & Ian Mackay (eds)]. [1007-1022] (Elsevier/Academic Press, New York), 2013.
27. Yule, T. D., Montoya, G. D., Russell, L. D., Williams, T. M. & Tung, K. S. Autoantigenic germ cells exist outside the blood testis barrier. J. Immunol. 141, 1161-1167 (1988).
28. Wheeler, K. et al. Regulatory T cells control tolerogenic versus autoimmune response to sperm in vasectomy. Proc. Natl. Acad. Sci. USA. 108, 7511-7516 (2011).
29. Starossom, S. C. et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37, 249-263 (2012).
30. Toscano, M. A. et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8, 825-834 (2007).
31. Iqbal, A. J. et al. Endogenous galectin-1 exerts tonic inhibition on experimental arthritis. J. Immunol. 191, 171-177 (2013).
32. Rabinovich, G. A. et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 190, 385-398 (1999).
33. Santucci, L. et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124, 1381-1394 (2003).
34. Toscano, M. A. et al. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2-And T regulatorymediated anti-inflammatory responses. J. Immunol. 176, 6323-6332 (2006).
35. Perone, M. J. et al. Suppression of autoimmune diabetes by soluble galectin-1. J. Immunol. 182, 2641-2653 (2009).
36. Timmons, P. M., Rigby, P. W. & Poirier, F. The murine seminiferous epithelial cycle is pre-figured in the Sertoli cells of the embryonic testis. Development 129, 635-647 (2002).
37. Ilarregui, J. M. et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 10, 981-991 (2009).
38. Blois, S. M. et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 13, 1450-1457 (2007).
39. Ramhorst, R. E. et al. Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss. Glycobiology 22, 1374-1386 (2012).
40. Bischoff, V., Deogracias, R., Poirier, F. & Barde, Y. A. Seizure-induced neuronal death is suppressed in the absence of the endogenous lectin Galectin-1. J. Neurosci. 32, 15590-15600 (2012).
41. Iqbal, A. J. et al. Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect. Am. J. Pathol. 178, 1201-1209 (2011).
42. He, J. & Baum, L. G. Presentation of galectin-1 by extracellular matrix triggers T cell death. J. Biol. Chem. 279, 4705-4712 (2004).
43. Muglia, C. et al. The glycan-binding protein galectin-1 controls survival of epithelial cells along the crypt-villus axis of small intestine. Cell Death Dis. 2, e163 (2011).
44. Hsu, D. K., Yang, R. Y., & Liu, F. T. Galectins in apoptosis. Methods Enzymol. 417, 256-273 (2006).
45. Matarrese, P. et al. Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission. J. Biol. Chem. 280, 6969-6985 (2005).
46. Brandt, B. et al. Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes. Histochem. Cell Biol. 129, 599-609 (2008).
47. Martinez, V. G. et al. Galectin-1, a cell adhesion modulator, induces apoptosis of rat Leydig cells in vitro. Glycobiology 14, 127-137 (2004).
48. Thijssen, V. L. et al. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res. 70, 6216-6224 (2010).
49. Mathieu, V. et al. Galectin-1 in melanoma biology and related neo-Angiogenesis processes. J. Invest. Dermatol. 132, 2245-2254 (2012).